IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma
Investigative and Clinical Urology · 2024 · 65 (1) · 84
DOI: 10.4111/icu.20230294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2024. Verfasst von Se Un Jeong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Membrane Proteins, RNA-Binding Proteins, Tyrosine Kinase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MSIP, Asan Institute for Life Sciences, Asan Medical Center, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- AI Recommendation, T3K, SK Telecom, Seoul, Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. yongcho@amc.seoul.kr.
ORCID-Profile: Se Un Jeong, Ja-Min Park, Sun Young Yoon, Hee Sang Hwang, Heounjeong Go, Dong-Myung Shin, Hyein Ju, Chang Ohk Sung, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho
Förderung
- MSIP
- Asan Institute for Life Sciences, Asan Medical Center
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Jeong, S. U., Park, J. M., Yoon, S. Y., Hwang, H. S., Go, H., Shin, D. M., Ju, H., Sung, C. O., Lee, J. L., Jeong, G., & Cho, Y. M. (2024). IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and Clinical Urology, 65(1), 84. https://doi.org/10.4111/icu.20230294
Vancouver
Jeong SU, Park JM, Yoon SY, Hwang HS, Go H, Shin DM, et al. IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and Clinical Urology. 2024;65(1):84. doi:10.4111/icu.20230294
BibTeX
@article{Jeong2024,
author = {Jeong, Se Un and Park, Ja-Min and Yoon, Sun Young and Hwang, Hee Sang and Go, Heounjeong and Shin, Dong-Myung and Ju, Hyein and Sung, Chang Ohk and Lee, Jae-Lyun and Jeong, Gowun and Cho, Yong Mee},
title = {IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma},
journal = {Investigative and Clinical Urology},
year = {2024},
volume = {65},
number = {1},
pages = {84},
doi = {10.4111/icu.20230294}
}
EUVIMED